Oblato open to CRO pitches for paediatric cancer candidate OKN-007, exec says Oblato is open to CRO pitches for a Phase I/II trial of its diffuse intrinsic pontine glioma (DIPG) candidate, said Jihye Sung, general manager of Business Development. The company plans to begin the trial in 2021 and complete it within two to three […]
Read More
Cancer Biopsy Market | Latest Trends Study Analysis Report to 2029 Biopsies have remarkably advanced the molecular medicine in general and oncology in particular. Technological strides in the devices used for biopsies have considerably improved the molecular characterization of cancers. They have been used popularly to diagnose the malignancy, identify the histology of the tumor, […]
Read More
Global Cancer Vaccines Market Outlook to 2030, by Technology Cancer Vaccines, Type, Indication … Dublin, Dec. 29, 2020 (GLOBE NEWSWIRE) — The “Cancer Vaccines Market by Technology Cancer Vaccines, Type, Indication, End User – Global Opportunity Analysis and Industry Forecast, 2019 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global cancer vaccines market […]
Read More
Lisa Ray Takes Break From Social Media, Says, ‘I’ll Be Back Online Next Year’ Four More Shots Please actor Lisa Ray took to her Twitter handle to share that she is taking a break from social media and will be back online next year. She wrote, “I wish you could feel how wistful this weather […]
Read More
Biotech Shares Pop On New Patent Announcement A Beverly Hills-based biotech company just announced the filing of U.S. and international patent applications, and the initiation of clinical development of TriKE™ therapy for the treatment of HER2+, HER3+ and HER2+/HER3+ heterodimer complex breast and gastrointestinal cancers. GT Biopharma Inc’s (OTCQB:GTBP) CEO commented that they “are pleased […]
Read More